SMSPHARMA.BO
Get informed when a big investor buys or sells
+ FollowOvervalued by 128.8% based on the discounted cash flow analysis.
| Market cap | $41.67 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.40 (0.09%) |
| Earnings per Share | $11.15 |
| Beta | 1.15 |
| Outstanding Shares | 93,762,331 |
| P/E Ratio | 39.56 |
|---|---|
| PEG | 1936.91 |
| Price to Sales | 4.61 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
SMS Pharmaceuticals Limited, an India-based entity, specializes in the production and commercialization of active pharmaceutical ingredients (APIs) and related intermediates. The company's extensive product portfolio addresses various th...